1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AUTOLUS THERAPEUTICS PLC - ADR
Autolus Therapeutics plc - ADR
XNAS: AUTL

Autolus Therapeutics PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUT...

Read More
1.45 -0.01 (-0.68%)
46.30% Fall from 52W High
341.0K
XNAS Volume

XNAS 13 Mar, 2026 11:02 AM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Autolus Therapeutics PLC (ADR) is on 20 Mar 2026 for the purpose of Autolus Therapeutics PLC Fourth Quarter Earnings Results for 2025 See details
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Expensive Valuation
19.7 / 100
Momentum Score
Technically Neutral
41.4 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
9
1Yr Price target upside is 520%
10 analysts

7

S

12

W

1

O

3

T

SWOT Analysis

Autolus Therapeutics PLC (ADR) Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..